HPCL share price gains as brokerages raise target prices after Q3 results. Should you buy, sell or hold the stock? - Qoneqt
seach-icon
  • user-img

    Vikshita Vitthal Gujaran in News

    29 Jan 11:40 AM


    thumbnail

    HPCL share price gains as brokerages raise target prices after Q3 results. Should you buy, sell or hold the stock?

    HPCL share price rose over 3% despite Q3 numbers below estimates; weaker marketing margins cited as the cause.

    Hindustan Petroleum Corporation (HPCL) share price rose over 3% on Monday's trading session even though the state-run oil marketing company's Q3 numbers came in below the Street's estimates. Weaker-than-expected marketing margins were the main cause of the shortfall, according to brokerage house Kotak Institutional Equities. HPCL has posted good 9MFY24 results despite a poorer 3Q; given the company's improving net worth and reduced debt levels as well as its ongoing high over-recoveries, there is a compelling case for retail price reductions shortly.

    Hindustan Petroleum Corporation share price opened at ₹434.95 apiece on BSE. HPCL share price touched an intraday high of ₹444.45 and an intraday low of ₹430.50 apiece.

    According to Rajesh Bhosale, Equity Technical and Derivative Analyst at Angel One HPCL stock prices were volatile last week; however, now they have started on a positive note, up around 1% in the morning session. However, prices may remain tentative at higher levels and may see selling at ₹450 as immediate resistance, whereas in the near term, prices may correct lower towards ₹410.

    Brokerage Kotak Institutional Equities increased its FY2024E EBITDA by 3% due to increased retail fuel over-recoveries in the fourth quarter of FY24.

    "We raise our FV to ₹360 (from ₹310) on higher EBITDA, higher value of investments and roll-over to December 2025 (from September 2025).While our concerns on OMCs’ marketing margins have eased, the recent run-up has been very strong (last 3M: HPCL up 75%, 63% outperformance versus Nifty). The stock now trades at 1.5X one-year forward P/BV (premium versus 1.1X LT average P/BV and at premium to 1.4X one-year forward P/BV for BPCL), which limits the upside, in our view. Maintain SELL," Kotak Institutional Equities said in its report.

    Source - Mint